PCOS Is Now PMOS: What the New Name Means for Patients in Frisco

If you have been diagnosed with PCOS, or you have been searching for answers to symptoms that sound like it, there is a piece of news worth knowing about. As of May 2026, PCOS has a new name: PMOS, Polyendocrine Metabolic Ovarian Syndrome. The change was published in The Lancet and endorsed by the Endocrine Society. It is not a new disease, a new diagnosis, or a change in how the condition is treated. It is a long-overdue update to the language clinicians use to describe a condition that affects roughly one in ten women of reproductive age.

At Legacy OB/GYN in Frisco, TX, we have decided to start using PMOS now, alongside PCOS, so our patients and the people in our community become familiar with the new name before it appears in lab orders, medical records, and pharmacy paperwork.

Here is what changed, what did not, and what patients in Frisco and across north Texas need to know.

Why the name changed

Polycystic Ovary Syndrome has always been a misleading name. Not every patient with the condition has visible cysts on their ovaries. The condition is also much more than ovarian. It is a whole-body endocrine and metabolic syndrome that affects hormones produced across multiple glands, influences insulin sensitivity and weight regulation, drives skin and hair symptoms, and shapes long-term cardiovascular and reproductive risk. Many clinicians and patient advocates have spent years pointing out that the name PCOS undersells the seriousness of the condition and contributes to underdiagnosis.

The rename to PMOS, Polyendocrine Metabolic Ovarian Syndrome, was the result of a multi-year global consensus process. The effort was led by Professor Helena Teede of Monash University, who also led the 2023 international evidence-based PCOS guideline. The process included thousands of stakeholders: clinicians across endocrinology, gynecology, fertility, and primary care; researchers; patient advocacy groups; and patients themselves. The final vote endorsed the new name decisively, 87 of 90 voting participants in favor.

The new name preserves continuity with the old. Polyendocrine reflects the multiple hormonal systems involved. Metabolic captures the cardiometabolic and weight-related dimensions. Ovarian preserves the structural features still often seen on imaging. Syndrome reflects that this is a constellation of related findings, not a single isolated test result.

What patients need to know

For people who already have a PCOS diagnosis, nothing about your care needs to change.

Your diagnosis remains valid. The diagnostic criteria for PMOS are the same criteria that defined PCOS. Your treatment plan continues unchanged. Whether you are managing symptoms with lifestyle, medication, hormonal therapy, fertility support, or coordinated care with an endocrinologist, the approach has not shifted. Your insurance coverage continues to apply. The diagnosis itself is unchanged. Only the name is being updated. Disease classification codes and electronic health record systems will be updated systematically over the planned three-year transition period.

You may begin to notice the new name appearing in different places:

• In your medical records and visit summaries
• On prescription labels and pharmacy paperwork
• In lab orders and ultrasound reports
• In educational materials, online resources, and the media
• In conversations with your care team

You do not need to do anything about any of this. If you ever see a term you are unsure about, our team is happy to clarify.

For people who think they might have PCOS but have not been evaluated, this name change does not change what to look for. Irregular or absent periods, unexplained weight changes, acne or excess facial and body hair, scalp hair thinning, signs of insulin resistance, and challenges with fertility remain the symptoms that often bring patients in. If any of those sound familiar, evaluation is straightforward and worth doing.

Why Legacy OB/GYN is using the new name now

Three reasons.

First, patient familiarity matters. The sooner the new name appears in patient-facing language, the easier the transition is when PMOS starts to show up in medical records and pharmacy systems. We would rather introduce the name in a calm, well-explained way than have a patient see it for the first time on a prescription label and wonder if something has changed.

Second, clinical practice should reflect the most current global consensus. Legacy OB/GYN is committed to evidence-based care. When the most rigorous global process for evaluating a clinical question reaches a clear conclusion, we adopt it. That is true for treatment guidelines, and it is true for terminology.

Third, we want to support the broader transition. Names matter in medicine. A condition that affects one in ten women deserves a name that accurately reflects what it is, not one that gives the impression it is a minor ovarian quirk.

How we work up PCOS and PMOS at Legacy

Every patient is a little different, but the workup follows a consistent pattern.

We start with a careful history. When did your cycles change? What are your most disruptive symptoms? Is there a family history of diabetes, thyroid disease, or PCOS / PMOS? We ask about weight changes, skin and hair, energy, sleep, and mood, because these are the dimensions PCOS / PMOS often shapes.

We run a focused panel of labs. The exact set depends on the picture, but typically includes a hormone panel (LH, FSH, total and free testosterone, DHEA-S, prolactin, TSH, and AMH where indicated) and a metabolic panel (fasting glucose, HbA1c, fasting insulin, and a full lipid profile). We order a pelvic ultrasound when imaging will change the plan.

We apply the Rotterdam criteria for diagnosis. Two of three findings (irregular cycles, signs of androgen excess on exam or labs, polycystic-appearing ovaries on ultrasound) supports the diagnosis. The new PMOS name does not change these criteria.

We talk about treatment as a conversation, not a prescription. Hormonal options, metabolic options (including inositol, metformin, and where appropriate, GLP-1 medications), targeted lifestyle changes that fit the week you actually live, and coordinated care with endocrinology and fertility when relevant. Treatment evolves with you.

Booking a visit

If you have PCOS, you are still our patient and your care is unchanged. If you suspect you might have PCOS or PMOS, or if you simply want a comprehensive evaluation, you are welcome to schedule a visit.

Call (972) 731-6565 or book online through the scheduling link on our website.

Our PCOS service page goes into more clinical depth, and the dedicated PMOS page explains the rename in additional detail.